Mersana Therapeutics, Inc. logo

Mersana Therapeutics, Inc. (MRSN)

Delisted
6 Jan 2026
NASDAQ (NGS) NASDAQ (NGS)
$
29. 08
0
0%
$
145.36M Market Cap
- P/E Ratio
- Div Yield
624,025 Volume
-1.53 Eps
$ 29.08
Previous Close
Investors:
Day Range
28.78 29.08
Year Range
5.21 30.39
Want to track MRSN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Mersana Therapeutics, Inc. logo
MRSN Mersana Therapeutics, Inc.
14 Nov 2025
-
-
Mersana Therapeutics, Inc. logo
MRSN Mersana Therapeutics, Inc.
6 Aug 2025
-
-
Mersana Therapeutics, Inc. logo
MRSN Mersana Therapeutics, Inc.
7 May 2025
-
-
Mersana Therapeutics, Inc. logo
MRSN Mersana Therapeutics, Inc.
26 Feb 2025
-
-
Mersana Therapeutics, Inc. logo
MRSN Mersana Therapeutics, Inc.
5 Nov 2024
-
-
Mersana Therapeutics, Inc. logo
MRSN Mersana Therapeutics, Inc.
6 Aug 2024
-
-
Mersana Therapeutics, Inc. logo
MRSN Mersana Therapeutics, Inc.
11 Jun 2024
-
-
Mersana Therapeutics, Inc. logo
MRSN Mersana Therapeutics, Inc.
9 May 2024
-
-
Mersana Therapeutics, Inc. logo
MRSN Mersana Therapeutics, Inc.
26 Feb 2024
-
-
Mersana Therapeutics, Inc. logo
MRSN Mersana Therapeutics, Inc.
6 Nov 2023
-
-